BE844544A - Insert ophtalmique pour le traitement du syndrome de l'oeil sec - Google Patents

Insert ophtalmique pour le traitement du syndrome de l'oeil sec

Info

Publication number
BE844544A
BE844544A BE169261A BE169261A BE844544A BE 844544 A BE844544 A BE 844544A BE 169261 A BE169261 A BE 169261A BE 169261 A BE169261 A BE 169261A BE 844544 A BE844544 A BE 844544A
Authority
BE
Belgium
Prior art keywords
treatment
dry eye
eye syndrome
ophthalmic insert
ophthalmic
Prior art date
Application number
BE169261A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE844544A publication Critical patent/BE844544A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE169261A 1975-07-29 1976-07-27 Insert ophtalmique pour le traitement du syndrome de l'oeil sec BE844544A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60016875A 1975-07-29 1975-07-29

Publications (1)

Publication Number Publication Date
BE844544A true BE844544A (fr) 1977-01-27

Family

ID=24402570

Family Applications (1)

Application Number Title Priority Date Filing Date
BE169261A BE844544A (fr) 1975-07-29 1976-07-27 Insert ophtalmique pour le traitement du syndrome de l'oeil sec

Country Status (16)

Country Link
US (1) US4343787A (fr)
JP (1) JPS5215811A (fr)
AU (1) AU509140B2 (fr)
BE (1) BE844544A (fr)
BR (1) BR7604876A (fr)
CH (1) CH631891A5 (fr)
CY (1) CY1137A (fr)
DE (1) DE2633988C2 (fr)
ES (3) ES450002A1 (fr)
FR (1) FR2319375A1 (fr)
GB (1) GB1543189A (fr)
HK (1) HK282A (fr)
IT (1) IT1062653B (fr)
NL (1) NL188266C (fr)
PT (1) PT65389B (fr)
SE (1) SE431508B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145207A (en) * 1978-04-30 1979-11-13 Agency Of Ind Science & Technol High viscosity eye lotion
US4436730A (en) 1979-06-25 1984-03-13 Polymer Technology Corporation Ionic opthalmic cellulose polymer solutions
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
FI831399A7 (fi) * 1982-04-29 1983-10-30 Agripat Sa Karkaistua polyvinyylialkoholia oleva piilolinssi
EP0108661A1 (fr) * 1982-10-04 1984-05-16 Merck & Co. Inc. Insertions oculaires en hydroxypropyl cellulose stabilisées et procédé de stérilisation
US4565198A (en) * 1983-12-27 1986-01-21 Barnes-Hind, Inc. Method for altering the curvature of the cornea
US4660546A (en) * 1984-11-07 1987-04-28 Robert S. Herrick Method for treating for deficiency of tears
US5209927A (en) * 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US5229128A (en) * 1986-06-11 1993-07-20 Haddad Heskel M Drug delivery ophthalmic insert and method of preparing same
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
GB8623661D0 (en) * 1986-10-02 1986-11-05 Darougar S Ocular insert
US5989579A (en) * 1986-10-02 1999-11-23 Escalon Medical Corp. Ocular insert with anchoring protrusions
CA1317226C (fr) * 1987-05-04 1993-05-04 Phillip E. Pennell Liquide visco-elastique pour chirurgie ophtalmique et methode d'utilisation
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
GB8917216D0 (en) * 1989-07-27 1989-09-13 Smith & Nephew Ophthalmic composition
FR2688694B1 (fr) * 1992-03-20 1999-06-25 Vetoquinol Sa Insert ophtalmique bioadhesif.
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
DK0732913T3 (da) 1993-04-30 2003-06-16 Nestle Sa Syntetisk viskoelastisk materiale til fysiologiske anvendelser, såsom oftalmiske anvendelser
US5631004A (en) * 1993-09-30 1997-05-20 Alcon Laboratories, Inc. Use of sustained release antibiotic compositions in ophthalmic surgical procedures
TW274516B (fr) * 1993-11-12 1996-04-21 Ciba Geigy Ag
US5773021A (en) * 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US5472436A (en) * 1994-07-26 1995-12-05 Fremstad; Daria A. Ocular appliance for delivering medication
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5518732A (en) * 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
DE19549506C2 (de) * 1995-03-07 1998-07-30 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation und Verfahren zur Herstellung derselben
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
US6193991B1 (en) * 1997-10-29 2001-02-27 Atul J. Shukla Biodegradable delivery systems of biologically active substances
WO2000051619A1 (fr) 1999-03-01 2000-09-08 Vista Scientific Llc Preparations ophtalmiques contenant de la mucine
US6264971B1 (en) 1999-11-04 2001-07-24 Btg International Limited Ocular insert
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002000137A1 (fr) * 2000-06-28 2002-01-03 Shukla Atul J Vehicules biodegradables et systemes d'administration de substances biologiquement actives
US7404825B2 (en) * 2001-06-11 2008-07-29 Herrick Ii Robert S Implant capable of forming a differential image in an eye
ATE506929T1 (de) 2001-06-12 2011-05-15 Univ Johns Hopkins Med Reservoirvorrichtung für die intraokulare arzneimittelabgabe
FR2833493B1 (fr) * 2001-12-18 2005-09-23 Ioltechnologie Production Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
US7442711B2 (en) * 2002-05-17 2008-10-28 Othera Holding, Inc. Amelioration of the development of cataracts and other ophthalmic diseases
EP1551399A4 (fr) * 2002-09-30 2011-01-05 Mark A Babizhayev Methode de traitement topique de maladies de l'oeil, composition et dispositif pour ce traitement
DE10246900A1 (de) 2002-10-08 2004-04-22 Horstmann, Michael, Dr. Am Auge applizierbare Vorrichtung zur sicheren Dosierung systemischer und tropischer Medikation
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
AU2004249137B2 (en) * 2003-06-13 2010-03-11 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
CN1835735B (zh) * 2003-08-20 2010-05-12 参天制药株式会社 微粒眼球筋膜下给药的药物释放系统
CA2536454C (fr) 2003-08-26 2013-03-26 Vista Scientific Dispositif d'administration oculaire de produit pharmaceutique
US7117870B2 (en) * 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US20060067978A1 (en) * 2004-09-29 2006-03-30 Bausch & Lomb Incorporated Process for preparing poly(vinyl alcohol) drug delivery devices
US20060068012A1 (en) * 2004-09-29 2006-03-30 Bausch & Lomb Incorporated Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
CA2617040A1 (fr) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. Systeme non invasif d'administration de medicament qui vise le tissu posterieur de l'oeil au moyen d'une composition solide
US20070265329A1 (en) * 2006-05-12 2007-11-15 Devang Shah T Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
US20070264339A1 (en) * 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations
US20070264338A1 (en) * 2006-05-12 2007-11-15 Shah Devang T Base-stabilized polyorthoester formulations
MX2009007774A (es) * 2007-02-09 2009-07-31 Alcon Inc Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros.
WO2008103613A2 (fr) 2007-02-22 2008-08-28 Othera Holding, Inc. Composés d'hydroxylamine et leurs procédés d'utilisation
AU2009324545A1 (en) * 2008-12-11 2011-06-30 A.P. Pharma, Inc. Methods for enhancing stability of polyorthoesters and their formulations
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
CN104887389B (zh) 2009-01-29 2017-06-23 弗赛特影像4股份有限公司 后段给药
US20100226962A1 (en) * 2009-03-03 2010-09-09 Rodstrom Theron R Peri-corneal drug delivery device
CN102596097B (zh) 2009-06-03 2015-05-20 弗赛特实验室有限责任公司 一种眼插入件
EP2486128A4 (fr) * 2009-10-08 2013-10-09 Neurotech Usa Inc Utilisation du pedf dans un système d'administration à base de cellules encapsulées
WO2011094170A1 (fr) * 2010-01-27 2011-08-04 Alcon Research, Ltd. Dispositif d'administration de médicaments péricornéens par intermittence
WO2013022801A1 (fr) 2011-08-05 2013-02-14 Forsight Vision4, Inc. Administration de petites molécules à l'aide d'un dispositif thérapeutique implantable
EP2585057B1 (fr) 2010-06-25 2017-08-23 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Méthode de traitement en utilisant acide sterculique
RU2013108836A (ru) 2010-07-29 2014-09-10 Илэвэн Байотерапьютикс, Инк. Агонисты и антагонисты гибридного рецептора il-1 i типа
ES2888906T3 (es) 2010-08-05 2022-01-10 Forsight Vision4 Inc Aparato inyector para la administración de fármacos
US9492315B2 (en) 2010-08-05 2016-11-15 Forsight Vision4, Inc. Implantable therapeutic device
AU2011285548B2 (en) 2010-08-05 2014-02-06 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
US20140031769A1 (en) 2010-11-19 2014-01-30 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
EP4249059B1 (fr) 2011-06-28 2025-07-30 ForSight Vision4, Inc. Un appareil pour collecter un échantillon de fluide à partir d'une chambre réservoir d'un dispositif thérapeutique pour l'oeil
WO2013040238A2 (fr) 2011-09-13 2013-03-21 Vista Scientific Llc Dispositifs d'administration de médicaments oculaires à libération prolongée et procédés de fabrication correspondants
WO2013040426A2 (fr) 2011-09-14 2013-03-21 Forsight Labs, Llc Appareil et procédés pour insert oculaire
PT2755600T (pt) 2011-09-16 2021-04-19 Forsight Vision4 Inc Aparelhos de troca de fluidos
DK2911623T3 (da) 2012-10-26 2019-10-28 Forsight Vision5 Inc Oftalmisk system til langvarig frigivelse af lægemiddel til øjet
JP6450364B2 (ja) 2013-03-13 2019-01-09 セセン バイオ， インコーポレイテッド 眼送達のためのキメラサイトカイン製剤
EP2968113B8 (fr) 2013-03-14 2020-10-28 Forsight Vision4, Inc. Systèmes pour l'administration intra-oculaire entretenue de composés à faible solubilité provenant d'un implant de système de pose d'orifice
EP2978393B1 (fr) 2013-03-28 2023-12-27 ForSight Vision4, Inc. Implant ophtalmique pour administrer des substances thérapeutiques
US9474756B2 (en) 2014-08-08 2016-10-25 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
US10500091B2 (en) 2014-11-10 2019-12-10 Forsight Vision4, Inc. Expandable drug delivery devices and methods of use
EP3283004A4 (fr) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Composition d'insert oculaire d'agent pharmaceutiquement actif cristallin ou semi-cristallin
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
CA3005238A1 (fr) 2015-11-20 2017-05-26 Forsight Vision4, Inc. Structures poreuses pour dispositifs d'administration de medicament a liberation prolongee
US11617680B2 (en) 2016-04-05 2023-04-04 Forsight Vision4, Inc. Implantable ocular drug delivery devices
JP7314155B2 (ja) 2017-11-21 2023-07-25 フォーサイト・ビジョン４・インコーポレーテッド 膨張可能ポート送達システムのための流体交換装置及びその使用方法
WO2021081117A2 (fr) 2019-10-24 2021-04-29 Labombard Denis E Dispositif oculaire et système d'administration de médicament, avec boîtier
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device
BE1030503B1 (fr) 2022-05-06 2023-12-04 Eyed Pharma Insert pour le traitement de la sécheresse oculaire
BE1030504B1 (fr) 2022-05-06 2023-12-04 Eyed Pharma Insert composite pour le traitement de la sécheresse oculaire
EP4518836A1 (fr) 2022-05-06 2025-03-12 Eyed Pharma Insert pour le traitement des yeux secs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3767788A (en) * 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
SE352811B (fr) * 1971-06-04 1973-01-15 Pharmacia Ab
US3845201A (en) * 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method
SE375007B (fr) * 1972-11-30 1975-04-07 Pharmacia Ab
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same
US3911098A (en) * 1974-02-11 1975-10-07 American Cyanamid Co Medicament carrier

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles

Also Published As

Publication number Publication date
CH631891A5 (en) 1982-09-15
BR7604876A (pt) 1977-08-09
AU509140B2 (en) 1980-04-24
GB1543189A (en) 1979-03-28
ES461217A1 (es) 1978-05-01
NL7607704A (nl) 1977-02-01
US4343787A (en) 1982-08-10
DE2633988C2 (de) 1986-09-11
ES461216A1 (es) 1978-05-01
HK282A (en) 1982-01-15
NL188266C (nl) 1992-05-18
SE7608036L (sv) 1977-01-30
JPS5215811A (en) 1977-02-05
ES450002A1 (es) 1977-11-16
FR2319375B1 (fr) 1982-07-23
JPS6122975B2 (fr) 1986-06-03
DE2633988A1 (de) 1977-02-10
NL188266B (nl) 1991-12-16
SE431508B (sv) 1984-02-13
PT65389B (en) 1978-06-09
CY1137A (en) 1982-05-07
AU1607776A (en) 1978-01-26
FR2319375A1 (fr) 1977-02-25
IT1062653B (it) 1984-10-20
PT65389A (en) 1976-08-01

Similar Documents

Publication Publication Date Title
BE844544A (fr) Insert ophtalmique pour le traitement du syndrome de l'oeil sec
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
BE875945A (fr) Derives anthraquinoniques pour le traitement des arthrites
FR2311818A1 (fr) Composition et procede pour le traitement de fibres keratiniques
BE843359A (fr) Preparation pour le traitement de parodontose
MA18939A1 (fr) Procede de preparation d'un agent pour le traitement de theilerioses
FR2340122A1 (fr) Composition anti-moussage pour le traitement de denrees alimentaires
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
IT8267795A0 (it) Composizione per trattamento del glaucoma
FR2304315A1 (fr) Lentille de contact pour inspection du fond de l'oeil
BE840614A (fr) Compositions pour le traitement des etoffes
FR2306710A1 (fr) Composition pour le traitement du colon
BE851775A (fr) Composition pour le traitement de la chevelure
BE878590A (fr) Agents anti-adherence pour le traitement du soufre
BE873092A (fr) Composition pour le traitement de l'hypertension
IT8267796A0 (it) Composizione per trattamento del glaucoma
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2300547A1 (fr) Agents pour le traitement des cheveux
BE858692A (fr) Composition pour le traitement de l'acne
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
IT8267794A0 (it) Composizione per trattamento del glaucoma

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0154

CCPV Grant of a supplementary protection certificate

Free format text: 093C0154, EXPIRES 20010727

RE20 Patent expired

Owner name: MERCK & CO. INC.

Effective date: 19960727